Feb 16, 2022 06:23AM Needham & Company Reiterates Buy Rating on CRISPR Therapeutics (CRSP), Foray Into Regenerative Medicine offers Large Market Potential

Apr 6, 2021 08:00AM CRISPR Therapeutics to Participate in the 20th Annual Needham Virtual Healthcare Conference

Dec 10, 2020 07:30AM CRISPR Therapeutics (CRSP) PT Raised to $170 at Needham & Company

Jul 29, 2020 08:37AM Companies with NDRs 7/29

Nov 19, 2019 11:32AM CRISPR Therapeutics (CRSP) PT Raised to $84 at Needham & Company

Apr 16, 2019 09:29AM Pre-Open Stock Movers 04/16: (ELF) (CRSP) (GH) Higher; (BRS) (WVE) (IP) Lower (more...)

Apr 1, 2019 07:00AM CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Nov 30, 2018 06:55AM Needham & Company Starts CRISPR Therapeutics (CRSP) at Buy

Sep 21, 2018 05:44AM CRISPR Therapeutics (CRSP) Prices 4.21M Share Common Offering at $47.50/Sh

Sep 20, 2018 08:33PM CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares

Sep 19, 2018 04:09PM CRISPR Therapeutics (CRSP) Announces $200M Offering of Common Shares

Sep 19, 2018 04:08PM CRISPR Therapeutics Announces Proposed Public Offering of Common Shares

Apr 17, 2018 09:22AM Pre-Open Movers 04/17: (RNDA) (ROKU) (NFLX) Higher; (BLCM) (LADR) (SEAC) Lower (more...)

Feb 21, 2018 08:30AM CRISPR Therapeutics to Participate in Four Upcoming Investor Conferences

Mar 30, 2017 08:00AM CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference